TY - JOUR
AU - Phillips, Emma
AU - van Enk, Sizèd
AU - Kildgaard, Sara
AU - Schlue, Silja
AU - Göttmann, Mona
AU - Jennings, Lauren Victoria
AU - Bethke, Frederic
AU - Müller, Gabriele
AU - Herold-Mende, Christel
AU - Pastor-Flores, Daniel
AU - Schneider, Martin
AU - Helm, Dominic
AU - Ostenfeld Larsen, Thomas
AU - Goidts, Violaine
TI - Malformin C preferentially kills glioblastoma stem-like cells via concerted induction of proteotoxic stress and autophagic flux blockade.
JO - Molecular oncology
VL - 19
IS - 3
SN - 1574-7891
CY - Hoboken, NJ
PB - John Wiley & Sons, Inc.
M1 - DKFZ-2024-02169
SP - 785-807
PY - 2025
N1 - #EA:B067#LA:B067# / 2025 Mar;19(3):785-807
AB - Glioblastoma is a highly aggressive brain tumor for which there is no cure. The dire prognosis of this disease is largely attributable to a high level of heterogeneity, including the presence of a subpopulation of tumor-initiating glioblastoma stem-like cells (GSCs), which are refractory to chemo- and radiotherapy. Here, in an unbiased marine-derived fungal extract screen, together with bioguided dereplication based on high-resolution mass spectrometry, we identified malformin C to preferentially induce cell death in patient-derived GSCs and explore the potential of this cyclic peptide as a therapeutic agent for glioblastoma. Malformin C significantly reduced tumor growth in an in vivo xenograft model of glioblastoma. Using transcriptomics and chemoproteomics, we found that malformin C binds to many proteins, leading to their aggregation, and rapidly induces the unfolded protein response, including autophagy, in GSCs. Crucially, chemical inhibition of translation using cycloheximide rescued malformin C-induced cell death in GSCs, demonstrating that the proteotoxic effect of the compound is necessary for its cytotoxicity. At the same time, malformin C appears to accumulate in lysosomes, disrupting autophagic flux, and driving cells to death. Supporting this, malformin C synergizes with chloroquine, an inhibitor of autophagy. Strikingly, we observed that autophagic flux is differentially regulated in GSCs compared with normal astrocytes. The sensitivity of GSCs to malformin C highlights the relevance of proteostasis and autophagy as a therapeutic vulnerability in glioblastoma.
KW - autophagy (Other)
KW - cancer (Other)
KW - compound screen (Other)
KW - glioblastoma (Other)
KW - proteostasis (Other)
KW - stem cells (Other)
KW - unfolded protein response (Other)
LB - PUB:(DE-HGF)16
C6 - pmid:39462997
DO - DOI:10.1002/1878-0261.13756
UR - https://inrepo02.dkfz.de/record/294336
ER -